| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kalra Balkrishan | President and CEO, Director | C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra | 05 Mar 2026 | 0001768217 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Award | +27,160 | +5.5% | $0.000000* | 525,007 | 03 Mar 2026 | Direct | F1, F2 | |
| transaction | G | Common Shares | Options Exercise | +2,800 | +0.53% | $27.65* | 527,807 | 04 Mar 2026 | Direct | ||
| transaction | G | Common Shares | Sale | $114,156 | -2,800 | -0.53% | $40.77 | 525,007 | 04 Mar 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Employee Stock Option (Right to Buy) | Options Exercise | -2,800 | -100% | $0.000000* | 0 | 04 Mar 2026 | Common Shares | 2,800 | $27.65 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date. |
| F2 | Includes 587 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on February 3, 2026. The reporting person currently holds a total of 8,962 shares under the ESPP. |
| F3 | The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.74 to $40.771. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F4 | The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. |